Company Filing History:
Years Active: 2013-2015
Title: Umashankara Muddegowda: Innovator in HIV-1 Research
Introduction
Umashankara Muddegowda is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of HIV-1 entry inhibitors. With a total of 2 patents, his work is recognized for its potential impact on public health.
Latest Patents
Muddegowda's latest patents focus on the development of active cores of peptide triazole HIV-1 entry inhibitors. The inventions provide a peptide triazole conjugate and its derivatives, along with methods for their use. Additionally, these patents include the development of an antibody to the peptide triazole conjugate and a method for identifying an HIV-1 entry inhibitor candidate. This innovative approach aims to enhance the effectiveness of treatments for HIV-1.
Career Highlights
Throughout his career, Umashankara Muddegowda has worked with prominent organizations such as the Philadelphia Health and Education Corporation and Drexel University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Irwin M Chaiken and Karyn McFadden. Their collaborative efforts have further advanced the research and development of HIV-1 entry inhibitors.
Conclusion
Umashankara Muddegowda's innovative work in the field of HIV-1 research highlights his commitment to improving public health through scientific advancements. His patents and collaborations reflect a dedication to finding effective solutions for complex health challenges.